Biologics in severe uncontrolled chronic rhinosinusitis with nasal polyps: A bicentric experience

BACKGROUND AND AIM: The introduction of biologics in the management of chronic rhinosinusitis with nasal polyposis (CRSwNP) has allowed for new therapeutic options and dupilumab represents the first approved biological agent. Aim of this paper is to provide a bicentric study in a real-life setting o...

Descripción completa

Detalles Bibliográficos
Autores principales: Bellocchi, Gianluca, Loperfido, Antonella, Passali, Francesco Maria, Millarelli, Stefano, Velletrani, Gianluca, Perla, Marco, Di Michele, Loreta, Di Girolamo, Stefano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mattioli 1885 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10644941/
https://www.ncbi.nlm.nih.gov/pubmed/37850768
http://dx.doi.org/10.23750/abm.v94i5.14745

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10644941/
https://www.ncbi.nlm.nih.gov/pubmed/37850768
http://dx.doi.org/10.23750/abm.v94i5.14745

Ejemplares similares